SyntheticMR

Be the first to follow this company

SyntheticMR is a technology company. The company operates in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that intends to increase the efficiency and quality of current MRI tests. The company was established in 2007 and is based in Linköping.

ShowingAll content types

Regulatory press releaseyesterday

SyntheticMR AB: SyntheticMR publishes disclosure document regarding rights issue

Regulatory press releaseyesterday

SyntheticMR AB: SyntheticMR offentliggör informationsdokument avseende företrädesemission

Regulatory press release12/17/2024, 1:51 PM

Announcement from extra general meeting in SyntheticMR AB (publ)

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Regulatory press release12/17/2024, 1:49 PM

Kommuniké från extra bolagsstämma i SyntheticMR AB (publ)

Press release12/6/2024, 7:44 PM

SyntheticMR AB: SyntheticMR receives FDA 510(k) clearance for SyMRI 15

Press release12/6/2024, 10:00 AM

Analysguiden: ANALYS SyntheticMR: Blickar mot 2025

Regulatory press release12/4/2024, 3:23 PM

SyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR

Regulatory press release12/4/2024, 3:19 PM

SyntheticMR AB (publ) utser Vedran Beglerbegovic till tillförordnad VD för SyntheticMR

Regulatory press release11/28/2024, 10:10 PM

Notice of extra general meeting in SyntheticMR AB (publ)

Regulatory press release11/28/2024, 10:10 PM

Kallelse till extra bolagsstämma i SyntheticMR AB (publ)

Regulatory press release11/28/2024, 10:05 PM

SyntheticMR AB: SyntheticMR resolves on a rights issue of approximately SEK 65 million

Regulatory press release11/28/2024, 10:05 PM

SyntheticMR AB: SyntheticMR beslutar om en företrädesemission om cirka 65 miljoner kronor

Regulatory press release11/28/2024, 9:55 PM

SyntheticMR AB: SyntheticMR signs agreement to acquire Finnish Combinostics Oy

Regulatory press release11/28/2024, 9:55 PM

SyntheticMR AB: SyntheticMR ingår avtal om att förvärva finska Combinostics Oy

Press release11/22/2024, 2:00 PM

SyntheticMR AB: Nomination Committee appointed for the 2025 Annual General Meeting in SyntheticMR

Press release11/22/2024, 1:57 PM

SyntheticMR AB: Valberedning utsedd inför årsstämman 2025 i SyntheticMR

Regulatory press release11/18/2024, 7:14 AM

SyntheticMR AB: Interim report July - September 2024

Regulatory press release11/18/2024, 7:11 AM

SyntheticMR AB: Delårsrapport juli - september 2024

Regulatory press release11/6/2024, 5:52 PM

SyntheticMR AB (publ) brings forward the publication date of the interim report for the period 1 January - 30 September 2024 to Monday, 18 November 2024.

Regulatory press release11/6/2024, 5:49 PM

SyntheticMR AB (publ) tidigarelägger offentliggörandet av delårsrapport för perioden 1 januari - 30 september 2024 till måndagen den 18 november 2024.

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.